{"id":419698,"date":"2021-01-22T16:03:10","date_gmt":"2021-01-22T21:03:10","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=419698"},"modified":"2021-01-22T16:03:10","modified_gmt":"2021-01-22T21:03:10","slug":"devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-a-debenture-holder","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-a-debenture-holder\/","title":{"rendered":"Devonian Announces the Issuance of Units in Settlement of Interests Owed to a Debenture Holder"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Devonian Announces the Issuance of Units in Settlement of Interests Owed to a Debenture Holder<\/b><\/p>\n<p>QUEBEC CITY&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nDevonian Health Group Inc. (\u201c <b>Devonian<\/b>\u201d or the \u201c <b>Corporation<\/b>\u201d) ( <b>TSXv: GSD<\/b>), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, announces today the issuance of the following units in settlement of interests owed to a holder of debentures issued in the private placement, as announced by press releases dated July 19, 2018:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\n252,055 units at a unit price of $0.20 (the \u201c<b>Units<\/b>\u201d) are issued to Aspri Pharma Canada Inc. (\u201c<b>Aspri<\/b>\u201d), holder of a debenture issued in the first tranche of the private placement closed on July 19, 2018. These Units are issued against the interest due to Aspri as of January 18, 2021 for a total amount of $50,411. Each Unit consists of one subordinate voting share and one warrant (a \u201c<b>Warrant<\/b>\u201d). Each Warrant gives its holder the right to subscribe to a subordinate voting share in the share capital of the Corporation at a price of $0.26 for a period of 48 months.\n<\/li>\n<\/ul>\n<p>\nThe issuance of Units is subject to the approval of the TSX Venture Exchange and will be subject to a hold period of 4 months and one day.\n<\/p>\n<p>\nThe settlement of interests in the form of Units of the Corporation takes place in favor of Aspri (for an amount of $50,411 or 252,055 Units), a holder of more than 10 % of the securities of the Corporation, which constitutes a \u201crelated party transaction\u201d within the meaning of<i> Regulation 61-101 respecting protection of minority security holders in special transactions<\/i> (\u201c<b>Regulation 61-101<\/b>\u201d) and within the meaning of Policy 5.9 of the Stock Exchange \u2013 <i>Protection of Minority securities holders in Special Transactions<\/i>. However, the directors of the Corporation who voted have determined that exemptions from the formal valuation and minority approval requirements provided for in sections 5.5 (a) and 5.7 (1) (a) of Regulation 61-101 respectively may be invoked as neither the fair market value of the Units issued to this insider nor the fair market value of the consideration paid does not exceeds 25 % of the market capitalization of the Corporation. No director of the Corporation has expressed a contrary opinion or disagreement in connection with the foregoing.\n<\/p>\n<p>\nA material change report relating to this transaction with a related party will be filed by the Corporation no later than 21 days prior to the date on which the subordinate voting shares and the Warrants are expected to be issued as the conditions of participation of unrelated persons on the one hand and related persons on the other hand in connection with the issuance of the subordinate voting shares and the Warrants were not determined.\n<\/p>\n<p><b>About Devonian<\/b><\/p>\n<p>\nDevonian Health Group Inc. is a late stage botanical pharmaceutical corporation with novel therapeutic approaches to targeting unmet medical needs. Devonian&#8217;s core strategy is to develop prescription botanical drugs from plant materials and algae for the treatment of inflammatory-autoimmune diseases including but not limited to ulcerative colitis and atopic dermatitis. Based on a foundation of over 15 years of research, Devonian\u2019s focus is further supported by a US-FDA set of regulatory guidelines favouring a more efficient drug development pathway for prescription botanical drug products over those of traditional prescription medicines. Devonian is also involved in the development of high-value cosmeceutical products leveraging the same proprietary approach employed with their pharmaceutical offerings. Devonian Health Group Inc. was incorporated in 2013 and is headquartered in Qu\u00e9bec, Canada where it owns a state-of-the art extraction facility with full traceability \u2018from the seed to the pill\u2019. Acquired in 2018, Altius Healthcare Inc., its commercialization partner, brings opportunities for further diversification and growth potential. Devonian is traded publicly on the TSX Venture Exchange (TSXv:GSD).\n<\/p>\n<p>\nFor more information, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.groupedevonian.com&amp;esheet=52366025&amp;newsitemid=20210122005310&amp;lan=en-US&amp;anchor=www.groupedevonian.com&amp;index=1&amp;md5=385328d39700be81f5b28b0be07ce0f8\">www.groupedevonian.com<\/a>.\n<\/p>\n<p><b>Forward Looking Statements<\/b><\/p>\n<p>\nThis press release contains forward-looking statements about Devonian\u2019s objectives, strategies and businesses that involve risks and uncertainties. These statements are \u201cforward-looking\u201d because they are based on our current expectations about the markets we operate in and on various estimates and assumptions. Actual events or results may differ materially from those anticipated in these forward-looking statements if known or unknown risks affect our business, or if our estimates or assumptions turn out to be inaccurate. Such risks and assumptions include, but are not limited to, Devonian\u2019s ability to develop, manufacture, and successfully commercialize value-added pharmaceutical and dermo-cosmeceutical products, the availability of funds and resources to pursue R&amp;D projects, the successful and timely completion of clinical studies, the ability of Devonian to take advantage of business opportunities in the pharmaceutical and dermo-cosmeceutical industries, uncertainties related to the regulatory process and general changes in economic conditions. You will find a more detailed assessment of the risks that could cause actual events or results to materially differ from our current expectations in Devonian\u2019s prospectus dated April 21<sup>st<\/sup>, 2017 under the heading \u201cRisk Factors\u201d related to Devonian\u2019s business. As a result, we cannot guarantee that any forward-looking statement will materialize. We assume no obligation to update any forward-looking statement even if new information becomes available, as a result of future events or for any other reason, unless required by applicable securities laws and regulations.\n<\/p>\n<p><i>Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.<\/i><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210122005310r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210122005310\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210122005310\/en\/<\/a><\/span><\/p>\n<p>\nDr Andr\u00e9 P. Boulet, PhD<br \/>\n<br \/>President and Chief Executive Officer<br \/>\n<br \/>Devonian Health Group Inc.<br \/>\n<br \/>Telephone: (514) 248-7509<br \/>\n<br \/>Email: <a rel=\"nofollow\" href=\"mailto:apboulet@groupedevonian.com\">apboulet@groupedevonian.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> North America Canada<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Biotechnology Pharmaceutical Health<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\" \/>\n","protected":false},"excerpt":{"rendered":"<p>Devonian Announces the Issuance of Units in Settlement of Interests Owed to a Debenture Holder QUEBEC CITY&#8211;(BUSINESS WIRE)&#8211; Devonian Health Group Inc. (\u201c Devonian\u201d or the \u201c Corporation\u201d) ( TSXv: GSD), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, announces today the issuance of the following units in settlement of interests owed to a holder of debentures issued in the private placement, as announced by press releases dated July 19, 2018: 252,055 units at a unit price of $0.20 (the \u201cUnits\u201d) are issued to Aspri Pharma Canada Inc. (\u201cAspri\u201d), holder of a debenture issued in the first tranche of the private placement closed on July 19, 2018. These Units are &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-a-debenture-holder\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Devonian Announces the Issuance of Units in Settlement of Interests Owed to a Debenture Holder&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-419698","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Devonian Announces the Issuance of Units in Settlement of Interests Owed to a Debenture Holder - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-a-debenture-holder\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Devonian Announces the Issuance of Units in Settlement of Interests Owed to a Debenture Holder - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Devonian Announces the Issuance of Units in Settlement of Interests Owed to a Debenture Holder QUEBEC CITY&#8211;(BUSINESS WIRE)&#8211; Devonian Health Group Inc. (\u201c Devonian\u201d or the \u201c Corporation\u201d) ( TSXv: GSD), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, announces today the issuance of the following units in settlement of interests owed to a holder of debentures issued in the private placement, as announced by press releases dated July 19, 2018: 252,055 units at a unit price of $0.20 (the \u201cUnits\u201d) are issued to Aspri Pharma Canada Inc. (\u201cAspri\u201d), holder of a debenture issued in the first tranche of the private placement closed on July 19, 2018. These Units are &hellip; Continue reading &quot;Devonian Announces the Issuance of Units in Settlement of Interests Owed to a Debenture Holder&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-a-debenture-holder\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-22T21:03:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210122005310r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-a-debenture-holder\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-a-debenture-holder\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Devonian Announces the Issuance of Units in Settlement of Interests Owed to a Debenture Holder\",\"datePublished\":\"2021-01-22T21:03:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-a-debenture-holder\\\/\"},\"wordCount\":936,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-a-debenture-holder\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210122005310r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-a-debenture-holder\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-a-debenture-holder\\\/\",\"name\":\"Devonian Announces the Issuance of Units in Settlement of Interests Owed to a Debenture Holder - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-a-debenture-holder\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-a-debenture-holder\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210122005310r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2021-01-22T21:03:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-a-debenture-holder\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-a-debenture-holder\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-a-debenture-holder\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210122005310r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210122005310r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-a-debenture-holder\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Devonian Announces the Issuance of Units in Settlement of Interests Owed to a Debenture Holder\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Devonian Announces the Issuance of Units in Settlement of Interests Owed to a Debenture Holder - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-a-debenture-holder\/","og_locale":"en_US","og_type":"article","og_title":"Devonian Announces the Issuance of Units in Settlement of Interests Owed to a Debenture Holder - Market Newsdesk","og_description":"Devonian Announces the Issuance of Units in Settlement of Interests Owed to a Debenture Holder QUEBEC CITY&#8211;(BUSINESS WIRE)&#8211; Devonian Health Group Inc. (\u201c Devonian\u201d or the \u201c Corporation\u201d) ( TSXv: GSD), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, announces today the issuance of the following units in settlement of interests owed to a holder of debentures issued in the private placement, as announced by press releases dated July 19, 2018: 252,055 units at a unit price of $0.20 (the \u201cUnits\u201d) are issued to Aspri Pharma Canada Inc. (\u201cAspri\u201d), holder of a debenture issued in the first tranche of the private placement closed on July 19, 2018. These Units are &hellip; Continue reading \"Devonian Announces the Issuance of Units in Settlement of Interests Owed to a Debenture Holder\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-a-debenture-holder\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-22T21:03:10+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210122005310r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-a-debenture-holder\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-a-debenture-holder\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Devonian Announces the Issuance of Units in Settlement of Interests Owed to a Debenture Holder","datePublished":"2021-01-22T21:03:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-a-debenture-holder\/"},"wordCount":936,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-a-debenture-holder\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210122005310r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-a-debenture-holder\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-a-debenture-holder\/","name":"Devonian Announces the Issuance of Units in Settlement of Interests Owed to a Debenture Holder - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-a-debenture-holder\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-a-debenture-holder\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210122005310r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2021-01-22T21:03:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-a-debenture-holder\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-a-debenture-holder\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-a-debenture-holder\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210122005310r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210122005310r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-a-debenture-holder\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Devonian Announces the Issuance of Units in Settlement of Interests Owed to a Debenture Holder"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/419698","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=419698"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/419698\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=419698"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=419698"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=419698"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}